The Effects of TMS on Memory-Consolidation in Human Primary Visual Cortex - Full Text View

The Effects of TMS on Memory-Consolidation in Human Primary Visual Cortex

This study is currently recruiting participants.
Verified by Sheba Medical Center, May 2007

Sponsored by:	Sheba Medical Center
Information provided by:	Sheba Medical Center
ClinicalTrials.gov Identifier:	NCT00480012

Purpose

Rapid Transcranial Magnetic Stimulation will be used in order to examine whether the human primary visual cortex is essential to visual memory consolidation.

Condition	Intervention
Healthy	Device: rTMS

MedlinePlus related topics:

Memory

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Basic Science, Randomized, Single Blind, Uncontrolled, Parallel Assignment

Official Title:	The Effects of Transcranial Magnetic Stimulation of the Brain on Memory-Consolidation in Human Primary Visual Cortex

Further study details as provided by Sheba Medical Center:

Estimated Enrollment:	60
Study Start Date:	May 2005

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	Yes

Criteria

Inclusion Criteria:

Healthy
Right handed

Exclusion Criteria:

Active/past neurological/psychiatric disorder
Personal/first-degree history of seizures
Cardio-vascular disorder or disease including hypertension chronic use of medication
Metal/electronic device implant
Pregnancy

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00480012

Contacts


Contact: Revital Amiaz, MD	972-52-6666571	revital.amiaz@sheba.health.gov.il

Locations


Israel
	Psychiatry Clinic - Sheba Medical Center	Recruiting
	Ramat-Gan, Israel
	Contact: Revital Amiaz, MD 972-52-6666571 revital.amiaz@sheba.health.gov.il

Sponsors and Collaborators

Sheba Medical Center

Investigators


Principal Investigator:	Revital Amiaz, MD	Sheba Medical Center

More Information

Study ID Numbers:	SHEBA-04-3437-RA-CTIL
First Received:	May 29, 2007
Last Updated:	May 29, 2007
ClinicalTrials.gov Identifier:	NCT00480012
Health Authority:	Israel: Israeli Health Ministry Pharmaceutical Administration

Keywords provided by Sheba Medical Center:

healthy subjects

Study placed in the following topic categories:

Healthy

ClinicalTrials.gov processed this record on December 10, 2008